HEATHER LAPPIN: Open Payments
NPI 1265877427 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 50 payments from 16 companies in 2025. Trend: 2023 $899 · 2024 $1,033 · 2025 $851
Food & beverage: $851
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $265 |
| PFIZER INC. | 6 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $86 |
| Lilly USA, LLC | 3 | $72 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 3 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
Products named: SKYRIZI, OMVOH, ENTYVIO, RINVOQ, DUPIXENT, VELSIPITY, ZENPEP, TREMFYA.
Industry payments across KS — which companies pay providers there.
